Collectively, PTL is thought to be beneficial for the treatment of COVID-19 via the inhibition of cytokine storm with NF-κB signalling pathways activation (Bahrami et al., 2020; Ouled Aitouna et al., 2021; Soleymani et al., 2022) (Table 1). Here, NFKB1 is linked to COVID-19.